Einsatz bildgebender Verfahren bei der Früherkennung von Mesotheliomen

• Literatur

• 1 Baas P, Fennell D, Kerr KM. et al Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26 (Suppl. 05) v31-v39 . Epub 2015 Jul 28
• 2 Hino O, Abe M, Han B. et al. In commemoration of the 2018 Mataro Nagayo Prize: A road to early diagnosis and monitoring of asbestos-related mesothelioma. Cancer Sci 2019; 110: 1518-1524
• 3 Johnen G, Burek K, Raiko I. et al. Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin – a case-control comparison nested into a prospective cohort of asbestos-exposed workers. Sci Rep 2018; 8: 14321
• 4 Kraus T, Teschler H. Update der AWMF-S2k-Leitlinie „Diagnostik und Begutachtung asbestbedingter Erkrankungen“ – Was gibt es Neues? [Update of the AWMF S2k Guideline „Diagnostics and Assessment of Occupational Asbestos-Related Diseases“ – What's New?]. Pneumologie 2021; 75: 201-205
• 5 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Malignant Pleural Mesothelioma Version 2.2019 — April 1, 2019 NCCN.org.
• 6 Protokollempfehlungen der AG DRauE zur Durchführung von Low-Dose-Volumen-HRCT-Untersuchungen der Lunge. Fortschr Röntgenstr 2017; 189: 553-575
• 7 Scherpereel A, Opitz I, Berghmans T. et al. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J 2020; 55: 1900953